Skip to main content

Stocks to keep an eye on June 23, 2015

( click to enlarge )
Sorrento Therapeutics Inc (NASDAQ:SRNE) hit a new 52-week high today, trading as high as $17.05, before settling at a close of $16.82. I'll be watching the stock on Tuesday, looking for a follow through move. Resistance reflects today’s high of $17.05.

( click to enlarge )
Stratasys, Ltd. (NASDAQ:SSYS) has been trying to bottom for a couple of days now. There have been some pretty bullish candles forming on daily and it seems to me like it is ready to turn up. For the first time in weeks, RSI chart has a positive crossover, indicating bullish outlook and MACD still rising. The next major resistance level for stock is located at $38.44. A close above would be very bullish. On watch.

( click to enlarge )
Vascular Biogenics Ltd (NASDAQ:VBLT) is showing some signs of a possible reversal. The daily technical chart is now much improved after today’s action. The Slow Sto has reversed again the course and stock regained its 100-day EMA. I bought some today at $6.38 and I think that it could go to $8 relatively soon. On watch.

( click to enlarge )
Bullish volume pattern. Looks like Bioline RX Ltd (NASDAQ:BLRX) has a good chance to continue higher and a buy could be made as it moves over $2.30. If this happens, BLRX is a good play. The daily technical chart above shows the stock is on a bull market as the stock is trading above all EMAs and MACD has a bullish crossover. In addition, the stock was upgraded by JP Morgan and Roth Capital today with a target price of $5 and $10.5 respectively. Let's keep an eye on it as i think momentum will pick up.

( click to enlarge )
Celladon Corp (NASDAQ:CLDN) closed the day just above the break out point after some decent swings. The stock may attempt to go higher from here. If the near-by support at $2.23 (EMA13) holds up this week, a rally up to the $2.76 level is probable or even possible. Only a close below $2.23 would negate the positive outlook.


Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.